Phenotype
|
Fish
|
Conditions
|
Figures
|
central artery structure, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 4.
from Cho et al., 2019
|
whole organism pcdh1g30 expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
whole organism ldlrb expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
whole organism myl4 expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
whole organism f7i expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
male organism biological process involved in interspecies interaction between organisms disrupted, exacerbated
|
dyrk1aakrb1/krb1
|
standard conditions
|
text only
from Aslanzadeh et al., 2019
|
male organism swimming increased duration, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
text only
from Aslanzadeh et al., 2019
|
brain hemorrhagic, abnormal
|
dyrk1aakrb1/krb1
|
heat shock
|
Fig. 1.
from Cho et al., 2019
|
social behavior process quality, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 4 ,
Fig. 6 ,
Fig. 7
from Kim et al., 2017
|
midbrain hemorrhagic, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 1.
from Cho et al., 2019
|
brain morphology, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 1. ,
Fig. 6.
from Cho et al., 2019
|
forebrain hemorrhagic, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 1.
from Cho et al., 2019
|
hindbrain vasculature kdrl expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S1
from Cho et al., 2019
|
retina hemorrhagic, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 1.
from Cho et al., 2019
|
locomotory exploration behavior process quality, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 3
from Kim et al., 2017
|
whole organism pcdh1g1 expression increased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
telencephalon decreased size, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. s2
from Kim et al., 2017
|
whole organism pcdh2ab10 expression increased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
central artery morphology, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 4.
from Cho et al., 2019
|
whole organism pcdh1g18 expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
whole organism pcdh1gc6 expression increased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
tectal ventricle increased size, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. s2
from Kim et al., 2017
|
brain hemorrhagic, ameliorated
|
dyrk1aakrb1/krb1
|
chemical treatment by environment: tacrolimus (anhydrous)
|
Fig. 8.
from Cho et al., 2019
|
brain hemorrhagic, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 1. ,
Fig. 3. ,
Fig. 6. ,
Fig. 8.
from Cho et al., 2019
|
brain hemorrhagic, ameliorated
|
dyrk1aakrb1/krb1
|
chemical treatment by environment: ethylene glycol bis(2-aminoethyl)tetraacetic acid
|
Fig. 6.
from Cho et al., 2019
|
brain apoptotic process increased process quality, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 2
from Kim et al., 2017
|
hindbrain vasculature dll4 expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S1
from Cho et al., 2019
|
brain morphology, abnormal
|
dyrk1aakrb1/krb1
|
heat shock
|
Fig. 1.
from Cho et al., 2019
|
whole organism capn8 expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
preoptic area crhb expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
stress, undercrowding
|
Fig. 5
from Kim et al., 2017
|
corpus cerebelli decreased size, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. s2
from Kim et al., 2017
|
whole organism capn2l expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
whole organism anxa1d expression increased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
optic tectum decreased size, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. s2
from Kim et al., 2017
|
brain decreased size, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 2 ,
Fig. s2
from Kim et al., 2017
|
diffuse nucleus inferior lobe fosab expression increased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 5
from Kim et al., 2017
|
male organism social behavior occurrence, exacerbated
|
dyrk1aakrb1/krb1
|
standard conditions
|
text only
from Aslanzadeh et al., 2019
|
brain apoptotic, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 2
from Kim et al., 2017
|
ventral hypothalamic zone fosab expression decreased amount, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 5
from Kim et al., 2017
|
hindbrain hemorrhagic, abnormal
|
dyrk1aakrb1/krb1
|
standard conditions
|
Fig. 1.
from Cho et al., 2019
|
male organism social behavior occurrence, abnormal
|
dyrk1aakrb1/+
|
standard conditions
|
text only
from Aslanzadeh et al., 2019
|
male organism swimming increased duration, abnormal
|
dyrk1aakrb1/+
|
standard conditions
|
text only
from Aslanzadeh et al., 2019
|
male organism biological process involved in interspecies interaction between organisms disrupted, abnormal
|
dyrk1aakrb1/+
|
standard conditions
|
text only
from Aslanzadeh et al., 2019
|
endothelial cell pcdh1g1 expression increased amount, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
central artery amount, ameliorated
|
dyrk1aakrb1/krb1; la116Tg
|
chemical treatment by environment: tacrolimus (anhydrous)
|
Fig. 8.
from Cho et al., 2019
|
endothelial cell capn2l expression decreased amount, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
endothelial cell pcdh1g18 expression decreased amount, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
endothelial cell capn8 expression decreased amount, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
central artery decreased branchiness, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. 1. ,
Fig. 3. ,
Fig. 6. ,
Fig. 8.
from Cho et al., 2019
|
central artery length, ameliorated
|
dyrk1aakrb1/krb1; la116Tg
|
chemical treatment by environment: ethylene glycol bis(2-aminoethyl)tetraacetic acid
|
Fig. 6.
from Cho et al., 2019
|
endothelial cell pcdh1gc6 expression increased amount, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
central artery branchiness, ameliorated
|
dyrk1aakrb1/krb1; la116Tg
|
chemical treatment by environment: ethylene glycol bis(2-aminoethyl)tetraacetic acid
|
Fig. 6.
from Cho et al., 2019
|
central artery length, ameliorated
|
dyrk1aakrb1/krb1; la116Tg
|
chemical treatment by environment: tacrolimus (anhydrous)
|
Fig. 8.
from Cho et al., 2019
|
endothelial cell pcdh1g30 expression decreased amount, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
central artery decreased length, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. 1. ,
Fig. 3. ,
Fig. 6. ,
Fig. 8.
from Cho et al., 2019
|
central artery morphology, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. 1. ,
Fig. 3. ,
Fig. 6.
from Cho et al., 2019
|
central artery structure, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. 1. ,
Fig. 3.
from Cho et al., 2019
|
central artery branchiness, ameliorated
|
dyrk1aakrb1/krb1; la116Tg
|
chemical treatment by environment: tacrolimus (anhydrous)
|
Fig. 8.
from Cho et al., 2019
|
central artery decreased amount, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. 8.
from Cho et al., 2019
|
endothelial cell myl4 expression decreased amount, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
endothelial cell pcdh2ab10 expression increased amount, abnormal
|
dyrk1aakrb1/krb1; la116Tg
|
standard conditions
|
Fig. S6
from Cho et al., 2019
|
central artery morphology, ameliorated
|
dyrk1aakrb1/krb1; la116Tg
|
chemical treatment by environment: ethylene glycol bis(2-aminoethyl)tetraacetic acid
|
Fig. 6.
from Cho et al., 2019
|